TGTX · Tg Therapeutics, Inc. · Debt
$57.35
-0.05 (-0.09%)
At close · Oct 29
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$8.83B
Shares
153.07M
Volume · Oct 29
998.67K
Avg daily vol (3M)
1.89M
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Noncurrent debt carrying amount | 2026-06-30 | USD 745,387,000 | 10-Q filed 2026-08-05 |
| Operating lease liabilities | 2026-06-30 | USD 9,054,000 | 10-Q filed 2026-08-05 |
Related accounting measures — not additional borrowingCarrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.
| |||
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Key facts
CIK
1001316
CUSIP
88322Q108
13F (30d)
118 filings
112 filers
Visit website
Investor relations